• Cat-intel
  • MedIntelliX
  • Resources
  • About Us
  • Hero Background
    English
    Chinese
    French
    Japanese
    Korean
    German
    Spanish

    Europe Diabetes Pen Market Trends

    ID: MRFR/MED/0171-HCR
    105 Pages
    Kinjoll Dey
    October 2025

    Europe, the Middle East and Africa Diabetes Pen Market- Forecast to 2035

    Share:
    Download PDF ×

    We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

    Europe Diabetes Pen Market Infographic
    $ 4,950.0
    $ 5,950.0
    $ 7,250.0

    Market Trends

    Key Emerging Trends in the Europe Diabetes Pen Market

    The EUROPE DIABETES PEN market is witnessing transformative trends in response to the increasing prevalence of diabetes, advancements in technology, and a growing focus on patient convenience. As an essential tool for insulin delivery, diabetes pens are evolving to meet the diverse needs of individuals managing diabetes across Europe. A primary driver of market trends is the rising incidence of diabetes in Europe. With an expanding diabetic population, the demand for effective and user-friendly insulin delivery devices like diabetes pens is on the rise, emphasizing the importance of convenient and accessible diabetes management tools. New technological advancements have been innovated every day and all these technology push for the differences in texture, style or mechanism of diabetic pens. Smart pens equipped with some features such as having dose memory, Bluetooth connectivity and the capability to track doses are being used more frequently it helps users in managing their insulin administration. It is clearly observable that European market moves towards prefilled insulin pens. The increased convenience provided by prefilled pens comes with the elimination of loading needed for manual insulin cartridge. This change streamlines the injection process, minimizes error potential and improves ease of use for people who have diabetes. In the market trends, pen needle safety is an issue of utmost importance. Manufacturers are incorporating safety features, including needle shields and the automatic needle retraction mechanism to help reduce needlestick injuries reducing overall compliance with diabetes pen use. The development of the features and design diabetes pens are influenced by patient-centric strategies. In the production of pens, manufacturers are paying attention to user wants and preferences based on respondents’ feedbacks that pertain with lifestyle as well as type of individual managing diabetes which promotes greater patient engagement and adherence in insulin therapy. Trending new features in the European diabetes pen market are customization and dose flexibility. The pens with adjustable dose settings and which allows for accurate insulin delivery meet the diverse needs of people living with diabetes; thus, a more individualized method in administering therapy. Integrated diabetes management solutions are becoming popular. Diabetes pens that can easily connect to glucose monitoring devices or mobile apps support a comprehensive approach in diabetes management, facilitating better tracking, processing data and coordinating insulin delivery with overall blood-glucose regulation. In Europe, sustainability has been rampant in the European market where manufacturers have considered eco-friendly materials and methods of design during diabetes pen production. This conforms to larger scale attempts at minimizing ecological footprint and respondent to growing need for environmentally responsible health care modalities. Educational initiatives and training programs are on the rise to ensure proper usage and understanding of diabetes pens. Manufacturers are investing in user-friendly interfaces, instructional materials, and training programs to empower individuals with diabetes to manage their insulin therapy effectively. Healthcare policies and reimbursement systems play a crucial role in shaping market trends. Changes in reimbursement policies influence the affordability and accessibility of diabetes pens, impacting both manufacturers and end-users across European healthcare systems.

    Market Summary

    The Europe, the Middle East and Africa Diabetes Pen market is projected to grow significantly from 18.47 USD Billion in 2024 to 47.19 USD Billion by 2035.

    Key Market Trends & Highlights

    Europe, the Middle East and Africa Diabetes Pen Key Trends and Highlights

    • The market is expected to experience a compound annual growth rate (CAGR) of 8.9 percent from 2025 to 2035. By 2035, the market valuation is anticipated to reach 47.2 USD Billion, indicating robust growth potential. in 2024, the market is valued at 18.47 USD Billion, reflecting a strong foundation for future expansion. Growing adoption of diabetes management technologies due to increasing prevalence of diabetes is a major market driver.

    Market Size & Forecast

    2024 Market Size 18.47 (USD Billion)
    2035 Market Size 47.19 (USD Billion)
    CAGR (2025-2035) 8.90%
    Largest Regional Market Share in 2024 latin_america)

    Major Players

    <p>Becton, Dickinson And Company, Novo Nordisk A/S, Ypsomed Holding Ag, Owen Mumford. Ltd, Sanofi, Eli Lilly, Merck Animal Health</p>

    Market Trends

    Technological Advancements in the Industry to Drive the Market Growth

    To regulate insulin, diabetic patients use an insulin pen or injection pen. It is a simple and convenient method for administering insulin via injection. It eliminates the need to hold the vial and syringe, allowing patients to administer insulin in the workplace or at school for their children. It requires significantly less time than syringes. There are two types of insulin syringes on the market: disposable and reusable. Diabetes pen improves quality of life and decreases hyperglycemia-related anxiety. Diabetes is becoming more prevalent, which has increased the demand for Diabetes pens.

    Diabetes pens are administered concurrently with the growing demand for insulin pens among diabetics. These devices used in conjunction with insulin syringes aid in administering the medication to the subject. Massive technological advancements also contribute to the expansion of the Diabetes pen market.

    Consumer Preference for Insulin Pens as Drug Delivery System

    Increasing use of innovative, reusable injection devices by diabetic patients is a further factor propelling the market forward. In addition, the growing prevalence of automated injection pens is a significant factor in the market expansion of injection pens. Due to their simplicity of use, precision, safety, and convenience in medication delivery, automated injection instruments are increasingly utilized by medical personnel. Injection pens are in high demand all over the world, not just in affluent nations where the geriatric population is at an increased risk for diseases such as diabetes and cancer.

    These elements are responsible for the expansion of the market.

    Diabetes pens should not be shared due to the risk of disease transmission, including hepatitis B. Diabetes pen needles with reduced lengths can be used with ease by all patients, including those who are overweight. These factors have positively anticipated propelling the development of the Europe, the Middle East and Africa Diabetes Pen Market.

    However, there are certain constraints and limitations that will impede the expansion of the Europe, the Middle East and Africa Diabetes Pen Market as a whole. Two types of insulin cannot be mixed in an insulin pen, thereby increasing the required injection frequency, which, in turn, inhibits the market's growth.

    Europe Diabetes Pen Market Market Drivers

    Market Segment Insights

    Europe, the Middle East and Africa Diabetes Pen Type Insights

    <p>The market, based on type, has been bifurcated into Disposable insulin pen, and reusable insulin pen. The reusable variable has the highest CAGR as a result of the rising demand for diabetic patients and the growing awareness of self-administration of insulin. The affordability of reusable insulins also contributes to the market expansion.</p>

    EME and Africa Diabetes Pen Therapy Insights

    <p>The market, based on type, has been segmented into Insulin, Glucagon-Like Peptide-1 (Glp-1), Growth Hormones.</p>

    Get more detailed insights about Europe Diabetes Pen Market– Forecast to 2034

    Regional Insights

    The market, based on region, has been focused on Europe, and Middle East and Africa regions.

    Europe is the largest market in the world and is anticipated to experience negligible expansion over the forecast period. This article attributes the development of the region to the widespread use of diabetes pens in the United Kingdom. In addition, the implementation of aggressive market penetration strategies by major market participants is anticipated to result in a rise in insulin pen adoption in the region over the forecast period.

    Due to rising consumer awareness of lifestyle-related diseases and the emergence of an inundation of preventative measures to combat the elevated sugar levels of individuals, the Middle East and Africa region is anticipated to experience constant and respectable growth. Due to the high prevalence of obese and overweight citizens, the incidence of diabetes in Saudi Arabia is rising significantly and is anticipated to remain high in the coming years. Iran, the second-largest country in the Middle East, has a significant diabetes problem due to its high prevalence rate, rising incidence rate, and economic impact.

    In Iran, diabetes-related mortality continues to rise; the age-adjusted fatality rate from diabetes has increased over time. Diabetes has significant economic ramifications for the nation. In addition to its high direct healthcare expenses, diabetes is a major risk factor for other chronic diseases, such as cardiovascular disease.

    Key Players and Competitive Insights

    As time progresses, the competitive landscape expands as individuals acquire novel and superior products that can generate market value.  The increasing prevalence of diabetes and favorable reimbursement scenario for pen needles, federal initiatives to raise awareness about injection techniques, increasing market penetration by leading players, the development of enhanced pen needle technologies, and ongoing projects will stimulate the market.

    Key Companies in the Europe Diabetes Pen Market market include

    Industry Developments

    July 2023: Injector pens for the low-cost insulins produced by Civica, Inc. was manufactured and supplied by Ypsomed AG beginning in July 2023.  Prior to this announcement, Civica stated that it planned to manufacture three insulin biosimilars: glargine, lispro, and aspart. Both vials and prefilled pens will be made available for purchase. The business hopes to sell the insulins at far lower prices than the competition. Civica will be able to help make self-administered treatment more affordable for Americans with diabetes with the assistance of Ypsomed, a recognized injectable device specialist with over 35 years of experience.

    Future Outlook

    Europe Diabetes Pen Market Future Outlook

    Market Segmentation

    Report Scope

    Attribute/Metric Details
    Market Size 2024   18.47 (USD Billion)
    Market Size 2025   20.11 (USD Billion)
    Market Size 2035 47.19 (USD Billion)
    Compound Annual Growth Rate (CAGR) 8.90% (2025 - 2035)
    Report Coverage Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
    Base Year 2024
    Market Forecast Period 2025 - 2035
    Historical Data 2020 - 2024
    Report Coverage Revenue Forecast, Market Competitive Landscape, Growth Factors, and Trends
    Segments Covered Type, Therapy & Regional Insights
    Geographies Covered Europe, the Middle East and Africa
    Key Companies Profiled Becton, Dickinson And Company, Novo Nordisk A/S, Ypsomed Holding Ag, Owen Mumford. Ltd, Sanofi, Eli Lilly, Merck Animal Health
    Key Market Opportunities Growing Adoption of Insulin Therapy
    Key Market Dynamics Prevalence of Diabetes, Technological Advancements.

    Market Highlights

    Author

    Kinjoll Dey
    Research Analyst Level I

    She holds an experience of about 6+ years in market research and business consulting, working under the spectrum of information communication technology, telecommunications and semiconductor domains. aarti conceptualizes and implements a scalable business strategy and provides strategic leadership to the clients. her expertise lies in market estimation, competitive intelligence, pipeline analysis, customer assessment, etc.

    Leave a Comment

    Latest Comments

    John Doe
    john@example.com

    This is a great article! Really helped me understand the topic better.

    Posted on July 23, 2025, 10:15 AM
    Jane Smith
    jane@domain.com

    Thanks for sharing this. I’ve bookmarked it for later reference.

    Posted on July 22, 2025, 7:45 PM

    FAQs

    1. Table of Contents 1 Introduction 1.1 Definition 1.2 Scope of the Study 1.2.1 Research Objectives 1.2.2 Assumptions & Limitations 1.3 Market Structure 2 Research Methodology 2.1 Research Process 2.2 Primary Research 2.3 Secondary Research 2.4 Forecast Model 3 Report Excerpt 4 Forecast Indicators 4.1 Introduction 4.2 Growth Drivers 4.3 Growth Barriers 4.5 Macroecnomical Indicators 5 Market Analysis 5.1 Porter's Five Force 5.2 Supply Chain Analysis 6 Europe, the Middle East and Africa Diabetes Pen Market, by Type 6.1 Disposable Insulin Pen 6.2 Reusable Insulin Pen 7 Europe, the Middle East and Africa Diabetes Pen Market, by Therapy 7.1 Insulin 7.2 Glucagon-Like Peptide-1 (Glp-1) 7.3 Growth Hormones 8 Europe, the Middle East and Africa Diabetes Pen Market, by Region 8.1 Introduction 8.2 EUROPE 8.2.1 GERMANY 8.2.2 FRANCE 8.2.3 U.K. 8.2.4 ITALY 8.2.5 SPAIN 8.2.6 Russia 8.3.7 REST OF EUROPE 8.3 Middle East & Africa 9 Competitive Landscape 9.1 Market Share Analysis 9.2 Competitive/Strategic Scenario 9.2.1 Mergers Acquisitions 9.2.2 Collaborations 9.2.3 Expansion 9.2.4 New Product Launches 10 Company Profiles 10.1 Becton, Dickinson And Company 10.2 Novo Nordisk A/S 10.3 Ypsomed Holding Ag 10.4 Owen Mumford, Ltd. 10.5 Sanofi 10.6 Eli Lilly 10.7 Merck Animal Health

    Europe Diabetes Pen Market Segmentation

    Market Segmentation Overview

    • Detailed segmentation data will be available in the full report
    • Comprehensive analysis by multiple parameters
    • Regional and country-level breakdowns
    • Market size forecasts by segment
    Infographic

    Free Sample Request

    Kindly complete the form below to receive a free sample of this Report

    Get Free Sample

    Customer Strories

    “I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

    Victoria Milne

    Founder
    Case Study
    Chemicals and Materials